contralateral to the pain in the insula, prefrontal, motor, SI and SII cortices, and lateral thalamus, with ipsilateral responses in the inferior parietal cortices. Interestingly, there were decreases in rCBF in the anterior cingulate cortex (Peyron et aI., 1998) . Increases and decreases in rCBF cannot be equated directly with net inhibition or excitation. However, the decreases in thalamic rCBF ob served both in the chronic neuropathic pain study of Hsieh and colleagues (1995) and during chronic cancer pain suggest differences in the modulation of the rCBF responses between acute and chronic pain (Jones, 1998) .
The decreases in rCBF with acute allodynic pain (Peyron et aI., 1998) in the context of increases in rCBF in ante rior cingulate cortex during experimental pain in all nor mal volunteer PET studies (Derbyshire et aI., 1998) sug gest substantial modulation of anterior cingulate function in this type of central deafferentation pain. So far, all PET studies of ongoing or tonic clinical pain have dem onstrated alterations in rCBF within components (thala mus, insula, prefrontal and anterior cingulate cortices) of the "pain matrix" that have high concentrations of opioid receptor binding (Jones et aI., 1994b) . These all are sub cortical or cortical components of the "medial pain sys tem" (Jones, 1998) , which is associated with processing of affective and higher cognitive aspects of nociception such as attention and aversive conditioning. No changes in rCBF in SI or SII have been associated with chronic pain. These cortical areas are the principal cortical pro jections of the "lateral pain system" and are associated more with aspects of localization and intensity coding (Treed et aI., 1999) . Notice that both primary occipital and somatosensory cortices are distinguished from other cortical areas by their low opioid receptor binding (Jones et aI., 1991c) . The common clinical observation that syn thetic opiates reduce the unpleasantness of the pain that still can be localized makes some sense of this physi ologic and pharmacologic division between the medial and lateral pain systems.
One candidate class of compounds that may have a role in modulating nociceptive responses within some of the components of the medial pain system are the en dogenous opioid peptides. Since these were discovered (Hughes, 1975) , their precise function in humans has remained elusive, although there is reasonable evidence for their involvement in the modulation of nociceptive processing in animals (Hollt et aI., 1985) . This is partly because of difficulties of access and partly because of difficulties with the use and interpretation of the effects of opiate antagonists such as naloxone. Techniques to measure availability of brain in vivo opioid receptor binding in human subjects have been developed using the opioid antagonist [ 11 C]diprenorphine and PET, which provide the possibility of measuring changes in occupancy of opioid receptors by endogenous opioid peptides (Jones et aI., 1994b) .
The other advantage of e l C]diprenorphine is that it has been previously shown that there is no correlation between rCBF and K/k2 or k3!k4 in normal volunteers (Jones et aI., 1994) . Previous studies (Jones et al., 1994a) have shown sub stantial changes in cerebral 11 C-diprenorphine binding in relation to chronic inflammatory pain states in patients with rheumatoid arthritis. The latter are consistent with changes in opioid peptide concentrations in the brain of arthritic animals (Panerai et aI., 1987) . We have used e l C]diprenorphine and PET (Jones et aI., 1987) in six patients with TN to evaluate whether similar changes in opioid receptor binding occur during the chronic neuro genic pain characteristic of this condition. The hypoth esis was that reduced e l C]diprenorphine binding would occur during ongoing pain as a result of increased occu pancy by endogenous opioid peptides, and that this would occur mainly within the components of the medial pain system.
METHODS
Six male patients (mean age 61.5 ± 9.5 years; range 46 to 72 years) with TN were studied. Each had a typical clinical pre-J Cereb Blood Flow Metab, Vol. 19, No. 7, 1999 sentation of TN with a mean length of history of 15 ± 8 years (range 3 to 26 years). Five subjects were right sided and one was left sided. All patients were affected by pain in the fol lowing trigeminal nerve divisions: the maxillary division (three patients), maxillary and mandibular divisions (two patients), or just the mandibular division (one patient). Routine diagnostic magnetic resonance (MR) imaging brain scans had been per formed. Results of these studies were normal in five patients, whereas an incidental subfrontal meningioma was found in one. All six patients were taking carbamazepine as their only medi cation with a mean dose of 800 ± 300 mg (range 400 to 1300 mg), which was kept constant throughout the duration of the study, spanning both presurgical and postsurgical scans. Three patients had no previous radiofrequency thermocoagulation (RFTC) treatments, whereas the others had undergone one, two, or three previous RFTC treatments.
Two PET studies were performed on each patient: one before RFTC treatment ("in pain"), and one within 3 weeks after treatment ("pain free"). The RFTC treatments were considered technically successful in all cases, producing analgesia in the appropriate trigeminal divisions while maintaining light touch sensibility.
Measures of pain, anxiety, and depression were performed before each scan: namely, the Visual Analogue score of pain within the previous 24 hours, and the Hospital Anxiety and Depression scale of anxiety and depression.
IIC-Diprenorphine PET studies were performed on the cn 953B PET scanner (Cn, Inc., Knoxville, TN, U.S.A.) at the MRC Cyclotron Unit. This scanner has retractable interplane septa and thus the ability to acquire all lines of coincidence between all planes (Spinks et aI., 1992) . The inplane resolution of the scanner in three-dimensional mode is 8.5 x 8.5 x 4.3 mm (full width-half maximum). After intravenous injection of IIC _ diprenorphine (specific activity range 7000 to 3800 mBq/ !-Lmol), a dynamic scan over 90 minutes was performed con sisting of 17 time frames (6 x 180 seconds, 3 x 240 seconds, 4
x 300 seconds. 4 x 600 seconds). For attenuation correction, a transmission scan was taken using three external line sources of germanium-68. To obtain the IIC-diprenorphine input function, continuous radioactivity monitoring of the subjects' arterial blood, with intermittent sampling to measure unchanged IIC _ diprenorphine and metabolites, was carried out (Jones et aI., 1987) ,
The PET images then were reconstructed on a Supercard SC I computer (CSPI, Billerica, MA, U.S.A.) and pixel-by pixel functional images obtained of the [IlCJdiprenorphine binding equivalent to total volume of distribution (Vdtot) using a spectral analysis technique Tadokoro et aI., 1993) . The use of Vdto! as a measure of spe cific binding of rllCjdiprenorphine is discussed in detail by Jones and associates (l994b) . It is directly proportional to the binding potential and has been shown to be independent of changes in CBF.
Correction of intrasubject head movement during each study was carried out using the Automated Image Registration pro gram (Woods et aI., J 992), which normalized each scan to the first image acquired. Results from preoperative and postopera tive scans were normalized to the standardized Talairach Atlas (Talairach and Tournoux, 1988; Friston et aI., 1991) and su perimposed on the standardized MR space. The data from the preoperative and postoperative studies were pooled into two normalized preoperative and postoperative images. The single patient with left-sided pain was mirror-transformed before group analysis, Statistical differences between the preoperative and postop-erative groups were analyzed. This included pixel-based analy sis of covariance (ANCOVA correction) to eliminate the effect of random global differences in e I C]diprenorphine binding between groups (Friston et a!.. 1990) . The statistical differences between the preoperative and postoperative groups were dis played as a statistical parametric map (Friston and Frackowiak, 1991) .
RESULTS
Results from the measures of pain, anxiety, and de pression performed before each scan were as follows. Between studies, the pain Visual Analogue score (which ranges from 0 [pain free] to 100 [maximal pain possible pain]) changed from a mean of 45 (range 12 to 73) to 0, whereas the scores on the Hospital Anxiety and Depres sion scale (a score greater than 9 on the depression sub scale indicates possible depression, and a score of lion the anxiety sub scale indicates possibly significant anxi ety) altered from a mean of 8.5 (anxiety) and 8.5 (de pression) to 4 and 3. 5, respectively. Statistical analysis on such small numbers was not considered appropriate.
All patients thus were rendered pain free with a reduction in associated anxiety and depression. All patients expe rienced pain on the day of their scan, but none of them experienced pain during the scanning period. Figure I demonstrates the statistical parametric map of the focal areas of significantly increased diprenorphine binding (P < 0. 01, t test) when patients were free of pain compared with when they were in pain, averaged across the whole group of six patients and normalized to the standardized Talairach Atlas (Talairach and Tournoux, 1988; Friston et aI., 1991) prefrontal (area 32: top row, images 5 and 6) insula (middle row, images I through 3), perigenual and mid cingulate (area 24: top row, image 5; bottom row, image 2), cingulofrontal transition (area 24/32) and inferior pa rietal (area 40: middle row, image 2) cortices, and the putamen and thalamus (middle row, images I through 3) ( Table 1) . Less convincing changes elsewhere (but no tably not in the primary somatosensory cortex) are not commented on further. Further analyses were performed excluding in turn the one patient with left-sided TN and the one patient with a subfrontal meningioma. The areas of increased binding found as a result of this subanalysis were not found to be significantly different.
DISCUSSION
Focal brain increases in diprenorphine binding when pain free are most likely to be caused by a decreased occupation of opioid receptors (fL, 8, and K) by endog enous opioid peptides, resulting in increased available sites for [ II Cldiprenorphine binding, up-regUlation of to tal binding sites, or both. This technique cannot distin guish between these possibilities. Two high and low spe cific activity scans in each state might go some way to achieve this (Sadzot et aI., 1991) but would have been unlikely to be acceptable to the patients. This entire pro cedure requires' that patients lie still in the scanner for a minimum of 2 hours. Changes in affinity state as an explanation for these results are less likely, since these have not been observed in the brain during experimental pain (Yonehara et aI., 1983) . The posttreatment scans were performed within 3 weeks of being rendered pain free and a mean of II days after the operation. It is unlikely that this response represents a nonspecific reac- tion to the stress of the operation or altered stress asso ciated with the actual scan, since previous studies in normal volunteers and patients suggest reproducible binding parameters for both pulse-chase and tracer-alone protocols (Jones et aI., 1994b) . Stress in animals has been shown to produce reductions in mainly subcortical in vivo eH]diprenorphine binding (Seeger et aI., 1984) rather than increases. Although it is possible that relative changes in rCBF may have a small effect on the V d lol of e l C]diprenorphine binding, this is unlikely to be sub stantial. It has been previously demonstrated that there is no correlation between rCBF and K/k2 or k3/k4 in nor mal volunteers (Jones et aI., 1987) , and it is therefore unlikely that the situation would be different in this group of patients. Anxiety, depression, and pain scores all improved af ter RFTC treatments with complete resolution of the pain. It is unlikely that the changes in [ II Cldiprenorphine binding are purely a result of the change in mood state, since the current evidence suggests that an increase rather than a decrease in binding should occur during depression. Substantial up-regulation of frontal and an terior cingulate opiate receptor binding, which may be compensatory for reduced opioid peptide release, has been well documented in suicide victims (Gross-Isseroff et aI., 1990) . Preliminary PET results have confirmed a similar finding in patients with depression (Mayberg et aI., 1991) . If this were a significant factor in our studies, this would produce the opposite effect of that observed. It is therefore likely that the major psychological com ponent resulting in the change in [ I I Cldiprenorphine binding is the change in the pain state. As far as we are aware, this is the first direct evidence for activation of the endogenous opioid system during neuropathic pain. Most of the areas where significant changes in binding oc curred also have been demonstrated to be implicated in acute (Jones et aI., 1991a; Talbot et aI., 1991; Jones et aI., 1992; Casey et aI., 1994) and tonic experimental pain processing (Derbyshire and Jones, 1998; Di Pierro et aI., 1994) . Most of these structures apart from dorsolateral prefrontal cortex also have been shown to be involved in the processing of chronic neuropathic pain (Hsieh et aI., 1995; Cesaro et aI., 1991) .
Although opiate receptors are widespread and have several different functions in the brain, previous in vivo PET studies using diprenorphine suggest that there are more discrete areas such as prefrontal cortex and anterior cingulate where endogenous opiates may have a discrete function in relation to chronic inflammatory pain (Jones et aI., 1994a) . Also notice that the synthetic mu-agonist fentanyl in analgesic doses also causes significant in creases in rCBF in bilateral prefrontal, anterior cingulate, and caudate nuclei (Firestone et aI., 1996) . Preliminary data suggest that morphine-induced analgesia for cancer pain is associated with increased rCBF in frontal, ante-rior cingulate, and insula cortices (Jones et aI., 1991b) .
From our own preliminary results, it appears that the main endogenous opiate responses are within the sub cortical and cortical projections of the so-called medial pain system. So far, no changes in opioid receptor bind ing have been observed in the cortical projections of the lateral pain system to the primary or secondary somato sensory cortices during either inflammatory or neuro pathic pain, the former having relatively low levels of opioid receptor binding (Jones et aI., 1991c) . Notice that the main differences in patterns of cortical activation in different types of chronic pain also have been in the anterior cingulate and prefrontal cortical (Derbyshire et aI., 1994; Jones et aI., 1997) responses.
The cortical projections of the medial pain system ap pear to be mainly concerned with the affective, atten tional, and intensity coding components of nociceptive processing, whereas the somatosensory cortex is more robustly activated when there is a prominent localization element to the stimulus (Jones, 1998) . This has been demonstrated by manipulating the affective components of a nociceptive stimulus while maintaining the intensity rating constant (Rainville et aI., 1997) using hypnosis and PET. Using a hypothesis-driven region of interest approach to the analysis, rCBF changes in the anterior cingulate cortex, were clearly correlated with changes in affective response with an absence of correlation in SI. It is therefore not surprising that the main changes in the endogenous opioid system should be found within the projections of the medial pain system.
Although early pain activation studies emphasize the lateralization of cerebral pain responses (Casey et aI., 1994; Talbot et aI., 1991) , subsequent studies with a more sensitive scanner in three-dimensional mode of ac quisition provide evidence for bilateral activation of an terior cingulate, insula, and prefrontal cortices and thala mus (Vogt et aI., 1996) .
After surgical pain relief of trigeminal neuralgic pain, there are significant increases in [ II C]diprenorphine binding within some of the cortical and subcortical com ponents of the pain matrix, consistent with the concept of decreased occupancy by endogenous opioid peptides when pain free. It is not within the scope of this experi ment to determine the physiologic consequences of the changes in [ 11 C]diprenorphine binding. However, in ani mals with experimentally induced acute prolonged pain, increased pain behavior has been demonstrated after in tracerebroventricular anti-l3-endorphin antibody (Porro et aI., 1999) . Interestingly, this was accompanied by in creased metabolic activity in several structures including the thalamus, caudate nucleus, parietal, cingulate, and frontal and insula cortices. This experiment neatly avoided some of the inherent problems associated with naloxone, including peripheral and central agonist and antagonist effects at different doses and the short cere-bral half-life. The new generation of enkephalinase in hibitors have been used to elicit the opposite behavioral effects to anti-l3-endorphin antibody (Chipkin et aI., 1988; Ruiz-Gayo et aI., 1992) . The substantially in creased bioavailability of these compounds provides the potential for human use. The exciting challenge for the future is to establish whether the substantial changes in the endogenous opioid system during trigeminal neural gic and other types of pain might be amenable to con trolled pharmacologic manipulation to further increase opioid receptor occupancy within the medial pain sys tem. The spare opioid binding capacity makes this sys tem amenable to such an approach. Positron emission tomography has been suggested as the technique of choice to establish the optimal dosing regimes for such compounds to achieve specific levels of opiate receptor occupancy and their physiologic effects in humans.
